Drugs / rF-NY-ESO-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00112957 | Dec 2004 → May 2009 | fallopian tube cancer, ovarian cancer, peritoneum cancer | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rF-NY-ESO-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00112957 ↗ |
| Modality | Vaccine | “rF-NY-ESO-1 vaccine” NCT00112957 ↗ |
| Route | Subcutaneous | “subcutaneous injections of rF-NY-ESO-1” NCT00112957 ↗ |